Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03752034 · ClinicalTrials.gov registry record · NA
Muscle Fiber Fragments for Improved Function of Rotator Cuff Musculature Following Rotator Cuff Repair
A NA study of Rotator Cuff, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03752034 is a NA study of Rotator Cuff that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03752034, a NA study of Rotator Cuff, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, a chest muscle sample (biopsy) will be taken and the muscle fibers will be removed from the sample and made into smaller strands or fragments. During this same procedure, those muscle fiber fragments (MFFs) will then be injected directly into the supraspinatus muscle. Once injected, the MFFs will remain in the supraspinatus where Investigators believe the MFF will become part of the participants' existing muscle and provide increased muscle size and strength, improving function (rotator cuff strength and stability).
Conditions Studied
Interventions
- OTHER Muscle Fiber Fragments (MFFs)
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03752034
The ClinicalTrials.gov registry entry for NCT03752034 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rotator Cuff appearing as the primary indexed condition, and to 1 intervention - of which Muscle Fiber Fragments (MFFs) is the first listed.
NCT03752034 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03752034 about?
NCT03752034 is a clinical study titled "Muscle Fiber Fragments for Improved Function of Rotator Cuff Musculature Following Rotator Cuff Repair". In this study, a chest muscle sample (biopsy) will be taken and the muscle fibers will be removed from the sample and made into smaller strands or fragments. During this same procedure, those muscle fiber fragments (MFFs) will then be injected directly into the supraspinatus muscle. Once injected, t...
What is the current status of trial NCT03752034?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2019-11-04. Estimated completion is 2026-12.
What conditions does trial NCT03752034 study?
This clinical trial studies the following conditions: Rotator Cuff.
What interventions are being tested in trial NCT03752034?
The interventions under investigation include: Muscle Fiber Fragments (MFFs) (OTHER).
Who is sponsoring clinical trial NCT03752034?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03752034 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.